BJDX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 May 2024 @ 16:00):

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States...

Stats
Today's Volume	17 146.00
Average Volume	54 062.00
Market Cap	1.41M
EPS	$0 ( 2024-05-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0600
ATR14	$0.0170 (3.24%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-13	Dey Svetlana	Buy	500	Common Stock
2023-12-13	Dey Indranil	Buy	500	Common Stock
2023-09-26	Scally Frances P	Buy	0
2023-03-24	Dey Svetlana	Buy	10 000	Common Stock
2023-03-28	Dey Indranil	Buy	2 000	Common Stock

INSIDER POWER
43.28
Last 55 transactions
Buy: 889 772 \| Sell: 456 992

Bluejay Diagnostics, Inc. Correlation

10 Most Positive Correlations
GNUS	0.978
BPYPP	0.971
SFBS	0.968
ADES	0.968
FFWM	0.966
SGMO	0.965
NUWE	0.965
ARVL	0.964
CARA	0.962
IMBI	0.962

10 Most Negative Correlations
VLAT	-0.964
AGFS	-0.964
ADAL	-0.962
TIOAU	-0.961
TIOA	-0.96
PPYAU	-0.956
ZING	-0.956
NVCN	-0.953
LDHA	-0.951
MSDAU	-0.95

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bluejay Diagnostics, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-780 955 (0.00 %)
EPS:	$-9.08

FY	2023
Revenue:	$0
Gross Profit:	$-780 955 (0.00 %)
EPS:	$-9.08

FY	2022
Revenue:	$249 040
Gross Profit:	$48 911.00 (19.64 %)
EPS:	$-9.15

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.275

Financial Reports:

No articles found.

Bluejay Diagnostics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.